Hence this literature confirms that alterations activation of WNT/PCP by WNT4 and WNT11, presence of FRZB, activation of MUSK, and LRP4 autoantibodies are used to diagnosis for the early and late stages of ALS, thereby early interventions can be initiated. This evidence concerns the gene FRZB and amyotrophic lateral sclerosis.